Multiple sclerosis therapeutics
What are new therapies teaching us about the immunology of multiple sclerosis?
News & Views in…Multiple sclerosis therapeutics
New trial to investigate if cannabis compounds can slow the progression of multiple sclerosis
‘Normal’ MRI scans in patients with optic neuritis may demonstrate a lower likelihood of developing MS
Correlation found between restless legs syndrome and multiple sclerosis
Trial Watch
Drug Watch
Research Highlights
Is Nogo-A a reliable biomarker for MS?
A role for cyclophosphamide in the treatment of MS?
Future treatments for multiple sclerosis
Dirucotide (MBP8298) for the treatment of multiple sclerosis
Novel designs for clinical trials in multiple sclerosis
Pharmacogenomics in multiple sclerosis
Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis
Management of pediatric multiple sclerosis
What is the optimal vitamin D level for health?
Bulletin Board
GSK cancer vaccine chosen for UK national HPV immunization program
Oxytocin may inhibit anxiety and have therapeutic implications for psychiatric affections
High-dose hyperbaric oxygen therapy may improve survival following cardiac arrest
Metformin may improve metabolic syndrome in obese children
Efficacy of tocilizumab, a humanized anti-IL-6 receptor antibody, in rheumatoid arthritis
Desmopressin for the treatment of adult nocturia
Dabigatran etexilate
Study of the extraction, purification and antidiabetic potential of ursolic acid from Cornus officinalis Sieb. et Zucc.
HIV drug policies and South markets